Foley Hoag LLP
Macrocyclic hepatitis C serine protease inhibitors
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Enata Pharmacueticals, Inc. AbbVie Inc.
A A A C A C
A61P A61P A61P C07D A61P C07K
inventional inventional inventional inventional inventional inventional
Brian E. Hui-Ju Yat Sun Albert W. Jorge Russell D. Steven C. Dennie S. Keith F. Guoqiang Jason P. Yonghua
Green Chen Or Kruger Gandarilla Cink Cullen Welch McDaniel Wang Shanley Gai